S. Serre

发表

Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization

J. Bukh, G. Leroux-Roels, P. Meuleman, 2010, Journal of Virology.

Identification of IFN-alpha Induced Envelope Mutations of Hepatitis C Virus In Vitro Associated

J. Bukh, H. Krarup, J. Gottwein, 2013 .

Fitness and Interferon Resistance Associated with Increased Viral Vitro In Envelope Mutations of Hepatitis C Virus Identification of Alpha Interferon-Induced

J. Bukh, H. Krarup, J. Gottwein, 2013 .

Identification of Alpha Interferon-Induced Envelope Mutations of Hepatitis C Virus In Vitro Associated with Increased Viral Fitness and Interferon Resistance

J. Bukh, H. Krarup, J. Gottwein, 2013, Journal of Virology.

Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor Resistance

J. Bukh, Yi-Ping Li, J. Gottwein, 2015, Antimicrobial Agents and Chemotherapy.

Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle

J. Bukh, H. Krarup, Yi-Ping Li, 2016, Antimicrobial Agents and Chemotherapy.

Running title : HCV genotype 2-6 protease inhibitor resistance 7 8

Yi-Ping Li, J. Gottwein, S. Serre, 2015 .

Analysis of the 5.8S rRNA Gene and the Internal Transcribed Spacers in Naegleria spp. and in N. fowleri

P. Pernin, M. Pélandakis, S. Serre, 2000, The Journal of eukaryotic microbiology.

HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape.

J. Bukh, K. Schønning, Qi Tang, 2019, Journal of hepatology.

Adapted J6/JFH1-Based Hepatitis C Virus Recombinants with Genotype-Specific NS4A Show Similar Efficacies against Lead Protease Inhibitors, Alpha Interferon, and a Putative NS4A Inhibitor

J. Bukh, N. Uzcátegui, H. Krarup, 2013, Antimicrobial Agents and Chemotherapy.

Combination Treatment with Hepatitis C Virus Protease and NS5A Inhibitors Is Effective against Recombinant Genotype 1a, 2a, and 3a Viruses

J. Bukh, T. Scheel, Yi-Ping Li, 2012, Antimicrobial Agents and Chemotherapy.

Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants

J. Bukh, J. Pawlotsky, C. Sarrazin, 2019, Hepatology.

Development and Application of Hepatitis C Reporter Viruses with Genotype 1 to 7 Core-Nonstructural Protein 2 (NS2) Expressing Fluorescent Proteins or Luciferase in Modified JFH1 NS5A

J. Bukh, G. Leroux-Roels, P. Meuleman, 2011, Journal of Virology.

Prognostic value of homocysteinemia in patients with congestive heart failure

F. Berthier, M. Candito, B. Houcher, 2006, Clinical chemistry and laboratory medicine.

Survival of rodent isolated Pasteurella pneumotropica, Staphylococcus aureus and Pseudomonas aeruginosa in different types of water

S. Serre, A. Kodjo, F. Veillet, 2004 .

Hypervariable Region 1 Deletion and Required Adaptive Envelope Mutations Confer Decreased Dependency on Scavenger Receptor Class B Type I and Low-Density Lipoprotein Receptor for Hepatitis C Virus

A. Nicosia, J. Bukh, Jens Bukh, 2013, Journal of Virology.

Dependency on Scavenger Receptor Class B Type I and Low Density Lipoprotein Receptor for 3

A. Nicosia, J. Bukh, Jannick Prentoe, 2013 .

Ralstonia pickettii-induced ataxia in immunodeficient mice.

M. Simon, V. Dangles-Marie, M. Bérard, 2009, Comparative medicine.

Factors associated with effective reassessment of antibiotic therapy on day 3.

C. Labate, P. Roger, S. Serre, 2013, Medecine et maladies infectieuses.